People 65 years and older and those who are moderately or severely immunocompromised should receive a second dose of 2024-2025 COVID-19 vaccine six months after their first dose. See the CDC's updated guidance. More Info
Laboratwa nou itilize a genyen done esè klinik yo disponib piblikman (https://www.medrxiv.org/content/10.1101/2020.04.11.20062372v1). Anplis de sa, Divizyon Sante Piblik Eta Delaware (State of Delaware Division of Public Health) la fè tès validasyon adisyonèl pou asire tès la egzat.